---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-326969"
form_type: "8-K"
ticker: "SRPT"
cik: "0000873303"
company_name: "Sarepta Therapeutics, Inc."
filed_at: "2025-12-19T23:59:59+00:00"
generated_at: "2026-05-16T12:40:59.208847+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Sarepta exchanges $291.4M of 1.25% notes for 4.875% notes due 2030 plus $31.6M cash

## Summary
- Exchanged ~$291.4M of existing 1.25% Convertible Senior Notes due 2027 for new 4.875% Convertible Notes due 2030 plus ~$31.6M cash.
- New notes issued as additional notes under August 2025 indenture; total 4.875% notes now ~$893.4M outstanding.
- Exchange involved holders including entity affiliated with board member Michael Chambers.
- Transaction closed December 18, 2025; extends maturity from 2027 to 2030 at higher coupon.

## SEC filing metadata
- accession: 0001193125-25-326969
- form_type: 8-K
- ticker: SRPT
- cik: 0000873303
- company_name: Sarepta Therapeutics, Inc.
- filed_at: 2025-12-19T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/873303/000119312525326969/0001193125-25-326969-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/873303/000119312525326969/d32354d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-326969
- JSON: https://secwatch.observer/filing/0001193125-25-326969.json
- Plain text: https://secwatch.observer/filing/0001193125-25-326969.txt

## Key facts
- Debt Financings
  Sarepta Therapeutics, Inc. incurred convertible notes of approximately $291.4 million with certain holders (including Michael A. Chambers Living Trust) at 4.875% maturing due 2030.
  - Instrument: convertible notes
  - Principal: approximately $291.4 million
  - Counterparty: certain holders (including Michael A. Chambers Living Trust)
  - Rate: 4.875%
  - Maturity: due 2030
  - Event: incurrence
  source text: the holders party thereto agreed to exchange with the Company approximately $291.4 million in aggregate principal amount of Existing Convertible Notes held by them for consideration consisting of (i) approximately $291.4 million in aggregate principal amount of 4.875% Convertible Senior Notes due 2030 (the “New Convertible Notes”) and (ii) an aggregate of approximately $31.6 million in cash.
  evidence_url: https://www.sec.gov/Archives/edgar/data/873303/000119312525326969/0001193125-25-326969-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.